InvestorsHub Logo
Followers 16
Posts 1914
Boards Moderated 0
Alias Born 03/30/2015

Re: None

Wednesday, 02/01/2017 2:30:30 PM

Wednesday, February 01, 2017 2:30:30 PM

Post# of 330329
I can help the group.

The volume ebbs and flows with conversions.

Regarding the FDA, BIEL knows something that they won't share, good or bad (if good, why not share?). I'm not saying they have a decision. I'm saying they know more than they've disclosed to the public.

The FDA clearance is a long shot given their generic indication for use. Efficacy relating to their selected and vague indication for use is going to be nearly impossible to prove.